Narcolepsy: etiology, clinical features, diagnosis and treatment
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0
Abstract
[u][/u] Narcolepsy is a chronic hypersomnia characterized by excessive daytime sleepiness (EDS) and manifestations of disrupted rapid eye movement sleep stage (cataplexy, sleep paralysis, and hypnagogic/hypnopompic hallucinations). Mechanisms underlying narcolepsy are not fully understood. Experimental data indicate that the disease is caused by a loss of hypocretin neurons in the hypothalamus, likely due to an autoimmune process triggered by environmental factors in susceptible individuals. Most patients with narcolepsy and cataplexy have very low hypocretin-1 levels in the cerebrospinal fluid. An appropriate clinical history, polysomnogram, and multiple sleep latency test are necessary for diagnosis of the disease. Additionally, two biological markers, i.e., cerebrospinal fluid hypocretin-1 levels and expression of the DQB1*0602 gene, are used. The treatment of narcolepsy is aimed at the different symptoms that the patient manifests. Excessive daytime sleepiness is treated with psychostimulants (amphetamine-like, modafinil and armodafinil). Cataplexy is treated with sodium oxybate (GHB), tricyclic antidepressants, or selective serotonin and noradrenaline reuptake inhibitors. Sleep paralysis, hallucinations, and fragmented sleep may be treated with sodium oxybate. Patients with narcolepsy should follow proper sleep hygiene and avoid strong emotions.
Authors and Affiliations
Jolanta Zawilska, Agata Woldan-Tambor, Anna Płocka, Katarzyna Kużajska, Jakub Wojcieszak
Keywords
Related Articles
- EP ID EP66793
- DOI -
- Views 150
- Downloads 0
Conjugated linolenic acids (CLnA, super CLA) – natural sources and biological activity
Polyunsaturated fatty acids (PUFA) have a wide range of biological activity. Among them conjugated fatty acids are of great interest. Conjugated linoleic acids (CLA), which exert a multidirectional health-benefiting infl...
Ostra białaczka promielocytowa – nowe podejście do patogenezy choroby i terapii różnicującej
W ciągu ostatnich lat rokowanie w grupie chorych z ostrą białaczką promielocytową (OBP) uległo radykalnej zmianie, a choroba z nieuleczalnej jeszcze dwadzieścia lat temu, stała się przykładem białaczki o bardzo dobrym ro...
Inflammation markers are associated with metabolic syndrome and ventricular arrhythmia in patients with coronary artery disease
Background: Inflammation plays a major role in the development and progression of atherosclerosis and coronary artery disease (CAD). Inflammation markers, including white blood cell (WBC) count, C-reactive protein (CRP)...
Heme metabolism as an integral part of iron homeostasis
Heme, a ferrous iron protoporphyrin IX complex, is employed as a prosthetic group in a number of diverse heme proteins that participate in important cellular and systemic physiological processes. Provision of an adequate...
„Błędne koła” glejaków: unaczynienie i inwazyjność
Glejak wielopostaciowy to szczególnie złośliwa postać nowotworu glejopochodnego. Nowotwór ten stanowi około 70% wszystkich zdiagnozowanych nowotworów mózgu. Niestety, średni czas przeżycia chorych na glejaki złośliwe nie...